We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
-11.28%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$557M
AUM Growth
+$24M
(+4.5%)
Cap. Flow
+$19M
Cap. Flow
% of AUM
3.41%
Top 10 Holdings %
Top 10 Hldgs %
30.34%
Holding
771
New
78
Increased
167
Reduced
171
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$24M |
| 2 |
iShares MSCI Mexico ETF
EWW
|
+$11.9M |
| 3 |
iShares MSCI Indonesia ETF
EIDO
|
+$8.83M |
| 4 |
Boeing
BA
|
+$6.9M |
| 5 |
BCE
BCE
|
+$4.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$30.9M |
| 2 |
iShares MSCI Taiwan ETF
EWT
|
+$9.78M |
| 3 |
Stellantis
STLA
|
+$8.56M |
| 4 |
Deutsche Bank
DB
|
+$7.5M |
| 5 |
iShares MSCI India ETF
INDA
|
+$5.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 11.37% |
| 2 | Technology | 8.96% |
| 3 | Industrials | 7.17% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Energy | 5.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Vail Resorts
MTN
$5.19B
| $33.5K | 0.01% |
159
+154
| +3,080% | +$38.1K |
|
|
AMAG
402
DELISTED
AMAG Pharmaceuticals
AMAG
| $33.5K | 0.01% |
2,206
-520
| -19% | -$9.91K |
|
403
Thor Industries
THO
$3.99B
| $33.1K | 0.01% |
+636
| New | +$43.1K |
|
404
Mondelez International
MDLZ
$77.7B
| $33.1K | 0.01% |
+826
| New | +$35.2K |
|
405
Public Service Enterprise Group
PEG
$39.8B
| $32.5K | 0.01% |
625
| – | – |
|
406
Live Nation Entertainment
LYV
$41.2B
| $32.2K | 0.01% |
+653
| New | +$34.5K |
|
|
IMMU
407
DELISTED
Immunomedics Inc
IMMU
| $32K | 0.01% |
+2,246
| New | +$44.6K |
|
408
United-Guardian
UG
$35M
| $31.2K | 0.01% |
+1,700
| New | +$29.2K |
|
409
Ciena
CIEN
$55.3B
| $30.8K | 0.01% |
908
| – | – |
|
410
McKesson
MCK
$98.5B
| $30.4K | 0.01% |
275
| – | – |
|
411
D.R. Horton
DHI
$41B
| $30.3K | 0.01% |
874
-25,806
| -97% | -$941K |
|
|
WFT
412
DELISTED
Weatherford International plc
WFT
| $30.2K | 0.01% |
54,093
+43,736
| +422% | +$57.1K |
|
413
Canadian Pacific Kansas City
CP
$82B
| $30.2K | 0.01% |
850
| – | – |
|
414
Ovintiv
OVV
$17.5B
| $28.9K | 0.01% |
1,000
| – | – |
|
|
GAU
415
Galiano Gold
GAU
$486M
| $28.7K | 0.01% |
45,000
| – | – |
|
416
Keurig Dr Pepper
KDP
$40.4B
| $28.7K | 0.01% |
1,119
| – | – |
|
417
RTX Corp
RTX
$287B
| $28.2K | 0.01% |
421
| – | – |
|
|
OXLC
418
Oxford Lane Capital
OXLC
$830M
| $28.1K | 0.01% |
579
| – | – |
|
419
Ventas
VTR
$48.9B
| $27.5K | ﹤0.01% |
469
| – | – |
|
420
Gold Fields
GFI
$29.2B
| $26.8K | ﹤0.01% |
7,616
| – | – |
|
|
SPPI
421
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $26.5K | ﹤0.01% |
+3,026
| New | +$38.5K |
|
422
Garrett Motion
GTX
$5.9B
| $25.4K | ﹤0.01% |
+2,063
| New | +$28K |
|
423
United States Oil Fund
USO
$2.27B
| $23.5K | ﹤0.01% |
304
-8,332
| -96% | -$839K |
|
424
SLB Ltd
SLB
$77.8B
| $23.1K | ﹤0.01% |
+641
| New | +$31.6K |
|
425
DuPont de Nemours
DD
$18.6B
| $22.5K | ﹤0.01% |
166
| – | – |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q4 2018 Portfolio in Review
As of Q4 2018, Exane Derivatives held 771 positions worth $557M, up 4.5% from $533M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Exane Derivatives deployed $19M of net new capital in Q4 2018, opening 78 new positions and adding to 167 existing holdings. Its largest new stake was Linde: 152,047 shares worth $24.1M.
By sector, the portfolio is most concentrated in Materials at 11% of assets, up from 6.4% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was iShares MSCI Taiwan ETF, an estimated $9.78M trimmed.
- Exane Derivatives's largest Q4 2018 buy was Linde: 152,047 shares worth $24.1M.
- Exane Derivatives added most to BCE in Q4 2018, an estimated $4.62M increase.
- Exane Derivatives's biggest Q4 2018 reduction was iShares MSCI Taiwan ETF, cutting an estimated $9.78M.
- Exane Derivatives fully exited UBS Group in Q4 2018, selling an estimated $30.9M.
- Exane Derivatives's ten largest holdings make up 30% of its $557M portfolio in Q4 2018.
- Exane Derivatives opened 78 new positions and closed 97 in Q4 2018.
- Exane Derivatives's portfolio value rose 4.5% quarter-over-quarter to $557M.
Based on Exane Derivatives's 13F filing for Q4 2018, filed 31 Jan 2019.